Dissecting glioblastoma risk signatures in the tumor immune microenvironment based on multi-dimensional transcriptomics
GigaScience · 21.01.2026 · 15
DOI: 10.1093/gigascience/giag035 ↗Kurz gefasst
Fachartikel in der Zeitschrift GigaScience, online erschienen am 25.03.2026. Verfasst von Tengyue Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioinformatics Science and Technology, Harbin Medical University, 157 Xuefu Road, Nangang District, Harbin 150081, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Glioblastoma, Transcriptome, Brain Neoplasms. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Major Project, National Natural Science Foundation of China, Key Research and Development Program of Heilongjiang Province.
Abstract (Originalsprache)
Glioblastoma (GBM) is characterized by pronounced tumor heterogeneity and a complex immune microenvironment, contributing to poor patient survival outcomes. In this study, we comprehensively dissected the tumor microenvironment (TME) and uncovered potential molecular mechanisms by integrating single-cell, bulk, and spatial transcriptomic data. Hallmarks of malignancy and cell cycle regulatory pathways were consistently enriched across these modalities, promoting tumor cell proliferation and progression. Using a machine learning algorithm, we identified seven hallmark-related prognostic signatures (HMsig), namely AEBP1, ASF1A, PRPS1, DCC, OPHN1, IL13RA2, and HDAC5—whose predictive importance was validated through SHAP analysis. Ligand–receptor (LR) interaction analysis further revealed that interactions involving OPHN1 were associated with poorer prognosis. Along the pseudotime trajectory of T cell differentiation, immune checkpoint genes (ICGs) LAG3, PDCD1, and HAVCR2 were substantially upregulated. Notably, synergistic transcriptional regulation between tumor-related HMsig genes and ICGs in T cells was identified as a key factor influencing patient survival. Spatial transcriptomic analysis demonstrated the existence of synergistic gene interactions, deciphering the immunomodulatory functions of GBM biomarkers within the TME.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Bioinformatics Science and Technology, Harbin Medical University, 157 Xuefu Road, Nangang District, Harbin 150081, China.
ORCID-Profile: Tengyue Li, Wanqi Mi, Huarui Yan, Yining Ma, Han Jiang, Xiaoxu Yang, Yunpeng Zhang, Congxue Hu
Förderung
- National Science and Technology Major Project
- National Natural Science Foundation of China
- Key Research and Development Program of Heilongjiang Province
- China Postdoctoral Science Foundation
- Heilongjiang Postdoctoral Fund
- Longjiang New Era Outstanding Doctoral Dissertation Project
- Harbin Medical University Fund
Zitieren
APA
Li, T., Mi, W., Yan, H., Ma, Y., Jiang, H., Yang, X., Zhang, Y., & Hu, C. (2026). Dissecting glioblastoma risk signatures in the tumor immune microenvironment based on multi-dimensional transcriptomics. GigaScience, 15. https://doi.org/10.1093/gigascience/giag035
Vancouver
Li T, Mi W, Yan H, Ma Y, Jiang H, Yang X, et al. Dissecting glioblastoma risk signatures in the tumor immune microenvironment based on multi-dimensional transcriptomics. GigaScience. 2026;15. doi:10.1093/gigascience/giag035
BibTeX
@article{Li2026,
author = {Li, Tengyue and Mi, Wanqi and Yan, Huarui and Ma, Yining and Jiang, Han and Yang, Xiaoxu and Zhang, Yunpeng and Hu, Congxue},
title = {Dissecting glioblastoma risk signatures in the tumor immune microenvironment based on multi-dimensional transcriptomics},
journal = {GigaScience},
year = {2026},
volume = {15},
doi = {10.1093/gigascience/giag035}
}
EUVIMED